|
|
Dr. David N. Maine is the first Jewish president and CEO of Mercy Health Services in its 145-year history. (Provided Photo)
Jmore talks with Dr. David N. Maine, the new president and CEO of Mercy Health Services, about what it’s like to be the Jewish head of a Catholic-based health system, how the pandemic is changing the nature of work at Mercy, and more.
Read MoreDr. Jonathan Thierman, Chief Medical Information Officer at LifeBridge Health, discusses the latest COVID-19 updates and trends and the medical impact on the Baltimore community.
Read MoreAs a result of the pandemic, Sheppard Pratt has created a virtual walk-in clinic offering accessible mental health care services.
Read More
To celebrate Sinai Hospital's storied past, a group of distinguished retired physicians and others recently gathered for a virtual program called, "Come Home to Sinai."
To celebrate Sinai Hospital’s storied past, a group of distinguished retired physicians and others recently gathered for a virtual program called, “Come Home to Sinai.”
Read More
Research teams at the University of Maryland are on the cutting edge of responding to the COVID-19 pandemic. (Provided Photo)
Research teams at the University of Maryland are on the cutting edge of responding to the COVID-19 pandemic.
Read More
Research by Dr. Yafit Gilboa of Jerusalem's Hebrew University on cognitive decline among cancer survivors has taken on added urgency in the age of the coronavirus. (Photo courtesy of Dr. Yafit Gilboa, via JTA)
Israeli researchers are discovering how stress affects the body’s fight against COVID-19 and how cancer survivors are impacted differently than otherwise healthy patients.
Read More
Dr. Shmuel Shoham: “There are certain populations of people who may not respond to [a COVID-19] vaccine, so it’s important to have this crowdsourced material available in the event of a vaccine shortage or for those who get the vaccine but also still get sick.” (Provided photo)
Jmore spoke with Dr. Shmuel Shoham about Johns Hopkins University School of Medicine’s COVID-19 clinical antibody trials, who is eligible to participate, and what the research could mean for the future of the pandemic.
Read More
Surgeons performing knee surgery at Hadassah hospital's Mount Scopus campus use the ROSA robot, made possible with a grant from USAID's Office of American Schools and Hospitals Abroad. (Gurion Rivkin)
Deluged by pandemic needs, Israeli doctors are getting help from an unlikely source: robots.
Read MoreFor months, doctors, nurses and other medical personnel, as well as researchers and mental health care professionals, have put their own personal safety on the line to save lives. Jmore proudly recognizes some of these health care heroes.
Read More
Dr. Shmuel Shoham: “If you are exposed to COVID-19, you have about a 20 percent chance of coming down with the virus. That means anything from sniffles to being really sick.”
At Johns Hopkins, doctors and researchers are conducting experiments and clinical trials to find answers about the coronavirus. Dr. Shmuel Shoham is one of those doctors, investigating the use of plasma from recovered survivors as a preventive treatment.
Read More
Dr. Matthew B. Frieman: “This new virus transmits just like a common cold virus, but is more fatal.”
For 16 years, Dr. Matthew B. Frieman, an associate professor of microbiology and immunology at the University of Maryland School of Medicine, has focused on studying coronaviruses. Now, his lab is working around the clock to find a way to combat COVID-19.
Read More
